Joanna Kucharczak
Overview
Explore the profile of Joanna Kucharczak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
10
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pearce J, Martin S, Heritage S, Khoury E, Kucharczak J, Nuamek T, et al.
J Natl Cancer Inst
. 2025 Jan;
PMID: 39886936
Background: It is increasingly recognised that frailty should be assessed and considered in treatment decision-making in patients with cancer. This review and meta-analysis synthesises existing evidence evaluating the association between...
2.
Vogt A, Faher A, Kucharczak J, Birch M, McCaskie A, Khan W
Int J Mol Sci
. 2025 Jan;
25(24.
PMID: 39769346
Mesenchymal stromal cells (MSCs) have the potential for novel treatments of several musculoskeletal conditions due to their ability to differentiate into several cell lineages including chondrocytes, adipocytes and osteocytes. Researchers...
3.
Shah V, Soh C, Chhatwal K, Kucharczak J, Airapetyan A, Avavde D, et al.
Minerva Surg
. 2024 Feb;
79(1):73-81.
PMID: 38381032
Introduction: Efforts to improve global healthcare persist, yet LMICs face challenges accessing surgical care, especially breast reconstruction amidst rising breast cancer cases. This review evaluates the present state and challenges...
4.
Khoury E, Nuamek T, Heritage S, Fulton-Ward T, Kucharczak J, Ng C, et al.
Cancers (Basel)
. 2023 Oct;
15(19).
PMID: 37835476
Cancer is a disease associated with ageing. Managing cancer in older adults may prove challenging owing to pre-existing frailty, comorbidity, and wider holistic needs, as well as the unclear benefits...
5.
Atallah E, Welsh S, OCarrigan B, Oshaughnessy A, Dolapo I, Kerr A, et al.
JHEP Rep
. 2023 Sep;
5(10):100851.
PMID: 37727807
Background & Aims: Checkpoint inhibitors (CPI) account for increasing numbers of drug-induced liver injury (DILI) cases. We aimed to determine the incidence rate and risk factors associated with checkpoint inhibitor-induced...
6.
Gunawardhana K, Hong L, Rugira T, Uebbing S, Kucharczak J, Mehta S, et al.
J Clin Invest
. 2023 Jan;
133(4).
PMID: 36602864
Genetic variants in the third intron of the PRDM6 gene have been associated with BP traits in multiple GWAS. By combining fine mapping, massively parallel reporter assays, and gene editing,...